# Ryder System Inc: financial statements, quarterly

R · NYSE · CIK 85961 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/r.md) · [Financials](/companies/r/financials.md) · [Filings](/companies/r/filings.md) · [Insiders](/companies/r/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/r/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,023 d](/filings/0000085961-26-000007.md) | [3,098](/filings/0000085961-25-000053.md) | [3,182](/filings/0000085961-25-000101.md) | [3,168](/filings/0001628280-25-046075.md) | [3,189 d](/filings/0000085961-26-000007.md) | [3,131](/filings/0001628280-26-026847.md) | [3,189](/filings/0001628280-26-049417.md) | [3,171](/filings/0001628280-26-066919.md) | [3,175 d](/filings/0000085961-26-000007.md) | [3,126](/filings/0001628280-26-026847.md) | [3,347](/filings/0001628280-26-049417.md) | [3,433](/filings/0001628280-26-066919.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [368 d](/filings/0000085961-26-000007.md) | [378](/filings/0000085961-25-000053.md) | [368](/filings/0000085961-25-000101.md) | [368](/filings/0001628280-25-046075.md) | [365 d](/filings/0000085961-26-000007.md) | [368](/filings/0001628280-26-026847.md) | [378](/filings/0001628280-26-049417.md) | [380](/filings/0001628280-26-066919.md) | [347 d](/filings/0000085961-26-000007.md) | [380](/filings/0001628280-26-026847.md) | [390](/filings/0001628280-26-049417.md) | [375](/filings/0001628280-26-066919.md) |
| Interest expense | $m | [84.0 d](/filings/0000085961-26-000007.md) | [92.0](/filings/0000085961-25-000053.md) | [96.0](/filings/0000085961-25-000101.md) | [98.0](/filings/0001628280-25-046075.md) | [100 d](/filings/0000085961-26-000007.md) | [100](/filings/0001628280-26-026847.md) | [102](/filings/0001628280-26-049417.md) | [102](/filings/0001628280-26-066919.md) | [100 d](/filings/0000085961-26-000007.md) | [97.0](/filings/0001628280-26-026847.md) | [97.0](/filings/0001628280-26-049417.md) | [96.0](/filings/0001628280-26-066919.md) |
| Income tax | $m | [36.0 d](/filings/0000085961-26-000007.md) | [29.0](/filings/0000085961-25-000053.md) | [52.0](/filings/0000085961-25-000101.md) | [45.0](/filings/0001628280-25-046075.md) | [46.0 d](/filings/0000085961-26-000007.md) | [36.0](/filings/0001628280-26-026847.md) | [52.0](/filings/0001628280-26-049417.md) | [51.0](/filings/0001628280-26-066919.md) | [44.0 d](/filings/0000085961-26-000007.md) | [25.0](/filings/0001628280-26-026847.md) | [52.0](/filings/0001628280-26-049417.md) | [64.0](/filings/0001628280-26-066919.md) |
| Net income | $m | [124 d](/filings/0000085961-26-000007.md) | [85.0](/filings/0000085961-25-000053.md) | [127](/filings/0000085961-25-000101.md) | [142](/filings/0001628280-25-046075.md) | [135 d](/filings/0000085961-26-000007.md) | [98.0](/filings/0001628280-26-026847.md) | [131](/filings/0001628280-26-049417.md) | [138](/filings/0001628280-26-066919.md) | [132 d](/filings/0000085961-26-000007.md) | [93.0](/filings/0001628280-26-026847.md) | [133](/filings/0001628280-26-049417.md) | [162](/filings/0001628280-26-066919.md) |
| Diluted EPS | $ per share | not reported | [1.89](/filings/0000085961-25-000053.md) | [2.84](/filings/0000085961-25-000101.md) | [3.24](/filings/0001628280-25-046075.md) | not reported | [2.27](/filings/0001628280-26-026847.md) | [3.13](/filings/0001628280-26-049417.md) | [3.32](/filings/0001628280-26-066919.md) | not reported | [2.33](/filings/0001628280-26-026847.md) | [3.39](/filings/0001628280-26-049417.md) | [4.15](/filings/0001628280-26-066919.md) |
| Basic EPS | $ per share | not reported | [1.93](/filings/0000085961-25-000053.md) | [2.89](/filings/0000085961-25-000101.md) | [3.30](/filings/0001628280-25-046075.md) | not reported | [2.32](/filings/0001628280-26-026847.md) | [3.18](/filings/0001628280-26-049417.md) | [3.38](/filings/0001628280-26-066919.md) | not reported | [2.36](/filings/0001628280-26-026847.md) | [3.43](/filings/0001628280-26-049417.md) | [4.21](/filings/0001628280-26-066919.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000085961-25-000032.md) | [0.2](/filings/0000085961-24-000078.md) | [0.2](/filings/0000085961-24-000138.md) | [0.2](/filings/0000085961-24-000156.md) | [0.2](/filings/0000085961-26-000007.md) | [0.2](/filings/0000085961-25-000053.md) | [0.2](/filings/0000085961-25-000101.md) | [0.2](/filings/0001628280-25-046075.md) | [0.2](/filings/0001628280-26-066919.md) | [0.2](/filings/0001628280-26-026847.md) | [0.2](/filings/0001628280-26-049417.md) | [0.2](/filings/0001628280-26-066919.md) |
| Current assets | $bn | [2.3](/filings/0000085961-25-000032.md) | [2.4](/filings/0000085961-24-000078.md) | [2.4](/filings/0000085961-24-000138.md) | [2.4](/filings/0000085961-24-000156.md) | [2.5](/filings/0000085961-26-000007.md) | [2.3](/filings/0000085961-25-000053.md) | [2.3](/filings/0000085961-25-000101.md) | [2.6](/filings/0001628280-25-046075.md) | [2.5](/filings/0001628280-26-066919.md) | [2.5](/filings/0001628280-26-026847.md) | [2.5](/filings/0001628280-26-049417.md) | [2.6](/filings/0001628280-26-066919.md) |
| Total assets | $bn | [15.8](/filings/0000085961-25-000032.md) | [16.5](/filings/0000085961-24-000078.md) | [16.4](/filings/0000085961-24-000138.md) | [16.5](/filings/0000085961-24-000156.md) | [16.7](/filings/0000085961-26-000007.md) | [16.4](/filings/0000085961-25-000053.md) | [16.5](/filings/0000085961-25-000101.md) | [16.5](/filings/0001628280-25-046075.md) | [16.4](/filings/0001628280-26-066919.md) | [16.2](/filings/0001628280-26-026847.md) | [16.1](/filings/0001628280-26-049417.md) | [16.2](/filings/0001628280-26-066919.md) |
| Current liabilities | $bn | [3.6](/filings/0000085961-25-000032.md) | [2.9](/filings/0000085961-24-000078.md) | [3.2](/filings/0000085961-24-000138.md) | [3.2](/filings/0000085961-24-000156.md) | [3.3](/filings/0000085961-26-000007.md) | [3.2](/filings/0000085961-25-000053.md) | [2.9](/filings/0000085961-25-000101.md) | [2.6](/filings/0001628280-25-046075.md) | [2.8](/filings/0001628280-26-066919.md) | [3.7](/filings/0001628280-26-026847.md) | [3.9](/filings/0001628280-26-049417.md) | [3.9](/filings/0001628280-26-066919.md) |
| Total liabilities | $bn | [12.7](/filings/0000085961-25-000032.md) | [13.4](/filings/0000085961-24-000078.md) | [13.3](/filings/0000085961-24-000138.md) | [13.4](/filings/0000085961-24-000156.md) | [13.6](/filings/0000085961-26-000007.md) | [13.4](/filings/0000085961-25-000053.md) | [13.4](/filings/0000085961-25-000101.md) | [13.5](/filings/0001628280-25-046075.md) | [13.3](/filings/0001628280-26-066919.md) | [13.4](/filings/0001628280-26-026847.md) | [13.2](/filings/0001628280-26-049417.md) | [13.2](/filings/0001628280-26-066919.md) |
| Long-term debt | $bn | [7.1](/filings/0000085961-24-000030.md) | not reported | not reported | not reported | [7.8](/filings/0000085961-25-000032.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [1.6](/filings/0000085961-25-000032.md) | [0.7](/filings/0000085961-24-000078.md) | [1.1](/filings/0000085961-24-000138.md) | [1.0](/filings/0000085961-24-000156.md) | [1.1](/filings/0000085961-26-000007.md) | [1.1](/filings/0000085961-25-000053.md) | [0.7](/filings/0000085961-25-000101.md) | [0.6](/filings/0001628280-25-046075.md) | [0.8](/filings/0001628280-26-066919.md) | [1.7](/filings/0001628280-26-026847.md) | [2.0](/filings/0001628280-26-049417.md) | [1.7](/filings/0001628280-26-066919.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.1](/filings/0000085961-26-000007.md) | [3.1](/filings/0000085961-25-000101.md) | [3.1](/filings/0001628280-25-046075.md) | [3.1](/filings/0001628280-25-046075.md) | [3.1](/filings/0001628280-26-066919.md) | [3.0](/filings/0001628280-26-049417.md) | [3.1](/filings/0001628280-26-066919.md) | [3.1](/filings/0001628280-26-066919.md) | [3.1](/filings/0001628280-26-066919.md) | [2.9](/filings/0001628280-26-049417.md) | [2.9](/filings/0001628280-26-066919.md) | [3.0](/filings/0001628280-26-066919.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [511 d](/filings/0000085961-26-000007.md) | [526](/filings/0000085961-25-000053.md) | [552 d](/filings/0000085961-25-000101.md) | [629 d](/filings/0001628280-25-046075.md) | [558 d](/filings/0000085961-26-000007.md) | [651](/filings/0001628280-26-026847.md) | [752 d](/filings/0001628280-26-049417.md) | [442 d](/filings/0001628280-26-066919.md) | [749 d](/filings/0000085961-26-000007.md) | [583](/filings/0001628280-26-026847.md) | [677 d](/filings/0001628280-26-049417.md) | [725 d](/filings/0001628280-26-066919.md) |
| Capital expenditure | $m | [777 d](/filings/0000085961-26-000007.md) | [686](/filings/0000085961-25-000053.md) | [639](/filings/0000085961-25-000101.md) | [599](/filings/0001628280-25-046075.md) | [761 d](/filings/0000085961-26-000007.md) | [514](/filings/0001628280-26-026847.md) | [689](/filings/0000085961-25-000101.md) | [527](/filings/0001628280-25-046075.md) | [405 d](/filings/0000085961-26-000007.md) | [427](/filings/0001628280-26-026847.md) | [405 d](/filings/0001628280-26-049417.md) | [543 d](/filings/0001628280-26-066919.md) |
| Dividends paid | $m | [32.0 d](/filings/0000085961-26-000007.md) | [35.0](/filings/0000085961-25-000053.md) | [31.0 d](/filings/0000085961-25-000101.md) | [35.0 d](/filings/0001628280-25-046075.md) | [34.0 d](/filings/0000085961-26-000007.md) | [38.0](/filings/0001628280-26-026847.md) | [33.0 d](/filings/0001628280-26-049417.md) | [37.0 d](/filings/0001628280-26-066919.md) | [37.0 d](/filings/0000085961-26-000007.md) | [39.0](/filings/0001628280-26-026847.md) | [35.0 d](/filings/0001628280-26-049417.md) | [39.0 d](/filings/0001628280-26-066919.md) |
| Share repurchases | $m | [55.0 d](/filings/0000085961-26-000007.md) | [51.0](/filings/0000085961-25-000053.md) | [90.0 d](/filings/0000085961-25-000101.md) | [141 d](/filings/0001628280-25-046075.md) | [39.0 d](/filings/0000085961-26-000007.md) | [167](/filings/0001628280-26-026847.md) | [94.0 d](/filings/0001628280-26-049417.md) | [89.0 d](/filings/0001628280-26-066919.md) | [169 d](/filings/0000085961-26-000007.md) | [233](/filings/0001628280-26-026847.md) | [99.0 d](/filings/0001628280-26-049417.md) | [40.0 d](/filings/0001628280-26-066919.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [47.5](/filings/0000085961-24-000078.md) | [46.0](/filings/0000085961-24-000138.md) | [46.3](/filings/0000085961-24-000156.md) | [45.0](/filings/0000085961-25-000053.md) | [44.6](/filings/0000085961-25-000101.md) | [43.9](/filings/0001628280-25-046075.md) | [42.9](/filings/0001628280-26-026847.md) | [41.8](/filings/0001628280-26-049417.md) | [41.6](/filings/0001628280-26-066919.md) | [39.6](/filings/0001628280-26-026847.md) | [38.9](/filings/0001628280-26-049417.md) | [38.8](/filings/0001628280-26-066919.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 38,218,715 at 2026-09-30, from the cover of the [10-Q filed 2026-10-22](/filings/0001628280-26-066919.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.